Small intestine bacterial overgrowth and fat digestion and absorption in cystic fibrosis patients;Jelitowy przerost bakteryjny a trawienie i wchłanianie tłuszczów u chorych na mukowiscydozę

Acta Scientiarum Polonorum, Technologia Alimentaria

Volumn 9, Issue 4, 2010, Pages 477-483

  Lisowska, Aleksandra ^a   Pogorzelski, Andrzej ^b   Oracz, Grzegorz ^c   Skorupa, Wojciech ^d   Cofta, Szczepan ^a   Socha, Jerzy ^c   Walkowiak, Jarosław ^a,e  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b National Institute for Tuberculosis and Lung Diseases   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^e POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Breath test; Cystic fibrosis; Lipid digestion and absorption; Small intestine bacterial overgrowth

Indexed keywords

FOOD TECHNOLOGY;

BREATH TESTS; CYSTIC FIBROSIS; LIPID DIGESTIONS; MOUSE MODELS; SMALL INTESTINE;

METABOLITES;

BACTERIA (MICROORGANISMS);

EID: 78249238832     PISSN: 16440730     EISSN: 18989594     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Armbrecht U., Bosaeus I., Gillberg R., Seeberg S., Stockbruegger R., 1985. Hydrogen (H2) breath test and gastric bacteria in acid-secreting subjects and in achlorhydric and postgastrectomy patients before and after antimicrobial treatment. Scand. J. Gastroenterol. 20, 805-813.
2. Borowitz D., Durie P.R., Clarke L.L., Werlin S.L., Taylor C.J., Semler J., De Lisle R.C., Lewindon P., Lichtman S.M., Sinaasappel M., Baker R.D., Baker S.S., Verkade H.J., Lowe M.E., Stallings V.A., Jnghorbani M., Butler R., Heubi J., 2005. Gastrointestinal outcomes and confounders in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 41, 273-285.
3. Bouhnik Y., Alain S., Attar A., Flourié B., Raskine L., Sanson-Le Pors M.J., Rambaud J.C., 1999. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am. J. Gastroenterol. 94, 1327-1331.
4. 2 breath test for small intestine bacterial overgrowth. Gastroenterology 98, 253-254.
5. Di Stefano M., Miceli E., Missanelli A., Mazzocchi S., Corazza G.R., 2005. Absorbable vs. nonabsorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment. Pharmacol. Ther. 21, 985-992.
6. Di Stefano M., Miceli E., Missanelli A., Corazza G.R., 2005. Treatment of small intestine bacterial overgrowth. Eur. Rev. Med. Pharmacol. Sci. 9, 217-222.
7. Eggermont E., 1996. Gastrointestinal manifestation in cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 8, 731-738.
8. Fridge J.L., Conrad C., Gerson L., Casteillo R.O., Cox K., 2007. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 44, 2, 212-217.
9. Goldin E., Wengrower D., 1990. Diarrhea in hypothyroidism: bacterial overgrowth as a possible etiology. J. Clin. Gastroenterol. 12, 98-99.
10. Gregg C.R., 2002. Enteric bacterial flora and bacterial overgrowth syndrome. Semin. Gastrointest. Dis. 13, 4, 200-209.
11. 13C MTG-BT) in healthy children and children with cystic fibrosis (CF) under pancreatic enzyme replacement therapy (PERT): A pilot study. Clin. Biochem. 41, 1489-1492.
12. Houwen R.H., van der Doef H.P., Sermet I., Munck A., Hauser B., Walkowiak J., Robberecht E., Colombo C., Sinaasappeal M., Wilschanski M., on behalf of the ESPGHAN Cystic Fibrosis Working Group, 2010. Defining DIOS and constipation in cystic fibrosis with a multicentre study in the incidence, characterictics, and treatment of DIOS. J. Pediatr. Gastroenterol. Nutr. 1, 50, 38-42.
13. Husebye E., 2005. The pathogenesis of gastrointestinal bacterial overgrowth. Chemiotherapy 51 (Suppl. 1), 1-22.
14. Kerlin P., Wong L., 1988. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95, 982-988.
15. Lisowska A., Ma{ogonek}dry E., Pogorzelski A., Szydłowski J., Radzikowski A., Walkowiak J., 2010. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand. J. Clin. Lab. Invest. Jun 21 [Epub ahead of print].
16. Lisowska A., Wójtowicz J., Walkowiak J., 2009. Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydfrogen and methane measurements are required for its detection. Acta Biochim. Pol. 56, 4, 631-634.
17. Norkina O., Burnett D.G., De Lisle R.C., 2004 a. Bacterial overgrowth in cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect. Immun. 72, 6040-6049.
18. Norkina O., Kaur S., Ziemer D., De Lisle R.C., 2004 b. Inflammation of the cystic fibrosis mouse small intestine. Am. J. Physiol. Gastrointest. Liver. Physiol. 286, G1032-1041.
19. Schneider A.R.J., Klueber S., Posselt H.-G., Funk B., Murzynski L., Caspary W.F., Stein J., 2009. Application of the glucose hydrogen breath test for the detection of bacterial overgrowth in patients with cystic fibrosis - a reliable method? Dig. Dis. Sci. 54, 1730-1735.
20. Singh V.V., Toskes P.P., 2003. Small bowel bacterial overgrowth: presentation, diagnosis and treatment. Curr. Gastroenterol. Rep. 5, 365-372.
21. Walkowiak J., Lisowska A., 2005. Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis. J. Pediatr. 147, 6, 870-871.
22. Walkowiak J., Lisowska A., Błaszczyński M., 2008. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype. Eur. J. Gastroenterol. Hepatol. 20, 3, 157-160.
23. Walkowiak J., Nousia-Arvanitakis S., Henker J., Stern M., Sinaasappel M., Dodge J.A., 2005. Indirect pancreatic function tests in children. J. Pediatr. Gastroenterol. Nutr. 40, 2, 107-114.